CUE
Cue Biopharma, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Cue Biopharma, Inc.
20.53
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BleichroederBleichroeder | $11.7M | 22.32% | new | |
| 2 | Driehaus Capital ManagementDriehaus | $9.2M | 17.59% | new | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $5.1M | 9.74% | new | |
| 4 | Ikarian CapitalIkarian Capital | $3.3M | 6.28% | new | |
| 5 | Polygon ManagementPolygon | $3.0M | 5.65% | new | |
| 6 | StemPoint CapitalStemPoint Capital | $2.1M | 4.03% | new | |
| 7 | BlackRockBlackRockindex-like | $1.8M | 3.48% | new | |
| 8 | ADAR1 Capital ManagementADAR1 | $1.7M | 3.32% | new | |
| 9 | Lion Point CapitalLion Point Capital | $1.7M | 3.19% | new | |
| 10 | Squadron Capital ManagementSquadron | $1.6M | 3.01% | new | |
| 11 | Diadema PartnersDiadema Partners | $1.5M | 2.91% | new | |
| 12 | Geode Capital ManagementGeodeindex-like | $1.5M | 2.88% | new | |
| 13 | Belvedere TradingBelvedere Trading | $1.1M | 2.10% | new | |
| 14 | Boothbay Fund ManagementBoothbay Fund | $992,846 | 1.89% | new | |
| 15 | UBS GroupUBS | $842,652 | 1.61% | −69.78% | |
| 16 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $772,463 | 1.47% | −95.50% | |
| 17 | Texas Capital Bank Wealth Management ServicesTexas Capital Bank Wealth Management Services | $722,124 | 1.38% | −94.24% | |
| 18 | Susquehanna International GroupSusquehanna International | $662,855 | 1.26% | new | |
| 19 | Renaissance TechnologiesRenaissance Technologies | $463,585 | 0.88% | new | |
| 20 | Persistent Asset PartnersPersistent Asset Partners | $389,198 | 0.74% | −63.04% | |
| 21 | Robertson Stephens Wealth ManagementRobertson Stephens Wealth | $351,357 | 0.67% | −97.67% | |
| 22 | Seven Fleet Capital ManagementSeven Fleet | $337,755 | 0.64% | new | |
| 23 | Northern TrustNorthern Trustindex-like | $287,890 | 0.55% | new | |
| 24 | Advisory ResearchAdvisory Research | $270,564 | 0.52% | new | |
| 25 | Stifel FinancialStifel Financial | $259,360 | 0.49% | −96.67% |
48 managers report $52.4M of Cue Biopharma on form 13F for the quarter ended Jun 30 '26. 11 of them hold 80% of it; Bleichroeder is largest at 22.32%.
Largest filed tie
—
Expected move
No implied move.
No implied move.
No implied move.